BWL
EBS icon

Bogart Wealth LLC’s Emergent Biosolutions EBS Stock Holding History

Bogart Wealth LLC’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$10K – 767
2021
Q3 		$10K Hold
200
– – ﹤0.01% 458
2021
Q2 		$13K Buy
200
+100
+100% +$6.42K ﹤0.01% 405
2021
Q1 		$9K Hold
100
– – ﹤0.01% 429
2020
Q4 		$8K Hold
100
– – ﹤0.01% 346
2020
Q3 		$10K Buy
+100
New +$10.8K ﹤0.01% 295

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bogart Wealth LLC's EBS Position: Q4 2021 in Review

Bogart Wealth LLC sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 200 shares — an estimated $10K sold.

Bogart Wealth LLC first reported a position in EBS in Q3 2020 and held it in 5 quarters. The position peaked at $13K in Q2 2021. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Bogart Wealth LLC reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Bogart Wealth LLC sold 200 Emergent Biosolutions shares in Q4 2021, an estimated $10K.
  • Bogart Wealth LLC first reported a position in Emergent Biosolutions in Q3 2020 and held it in 5 quarters.
  • Bogart Wealth LLC's Emergent Biosolutions position peaked at $13K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Bogart Wealth LLC's 13F filing for Q4 2021, filed 19 Jan 2022.